Method for treating alzheimer's disease
US6127370A · kind A · utility
37Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 1999 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Nov 8, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating occlusive vascular disease or Alzheimer's disease, wherein the patient has at least moderately elevated blood levels of homocysteine and at least moderately reduced blood levels of folate and vitamin B.sub.12, wherein the patient is treated with folic acid, a folate or a derivative thereof, and optionally vitamin B.sub.12, and optionally an organic nitrate such as isosorbide mononitrate or dinitrate, or an ACE inhibitor or an angiotensin II antagonist, or a NEP/ACE inhibitor or a combination of two or more of the above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.